Ikesue Hiroaki 池末裕明

… Alternative Names

池末裕明イケスエヒロアキ

IKESUE HIROAKI 池末裕明

Less

Researcher Number	60748010
Other IDs
Affiliation (Current)	2025: 名古屋大学, 医学部附属病院, 教授 2025: 公益財団法人神戸医療産業都市推進機構, その他部局等, 研究員 2025: 神戸学院大学, 薬学研究科, 連携准教授
Affiliation (based on the past Project Information) *help	2023: 地方独立行政法人神戸市民病院機構神戸市立医療センター中央市民病院(第1診療部、第2診療部、第3診療部, 中央市民病院, 薬剤部副部長 2016 – 2020: 神戸学院大学, 薬学研究科, 連携准教授 2015: 九州大学, 大学病院, その他
Review Section/Research Field	Principal Investigator Basic Section 47060:Clinical pharmacy-related / Applied pharmacology
Keywords	Principal Investigator 副作用 / デノスマブ / 骨転移治療薬 / 安全性向上 / 免疫チェックポイント阻害薬 / 骨転移 / 副作用対策 / 有害事象 / がん薬物療法 / 顎骨壊死 … More / 低カルシウム血症 / 薬剤性腎障害 / 癌骨転移治療薬 / 腎機能 / ゾレドロン酸 / がん Less

免疫チェックポイント阻害薬の副作用早期発見のための指標と安全な診療体制の確立Principal Investigator
- Principal Investigator
  
  池末裕明
- Project Period (FY)
  2023 – 2025
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Review Section
  
  Basic Section 47060:Clinical pharmacy-related
- Research Institution
  Kobe City Medical Center General Hospital(First Clinical Division, Second Clinical Division, Third
Management of adverse events associated with pharmacotherapy in cancer patients with bone metastasisPrincipal Investigator
- Principal Investigator
  
  Ikesue Hiroaki
- Project Period (FY)
  2018 – 2020
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Review Section
  
  Basic Section 47060:Clinical pharmacy-related
- Research Institution
  Kobe Gakuin University
Development of monitoring adverse events assciated with bone modifiers in patients cancer bone metastasesPrincipal Investigator
- Principal Investigator
  
  IKESUE HIROAKI
- Project Period (FY)
  2015 – 2017
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Applied pharmacology
- Research Institution
  Kobe Gakuin University
  Kyushu University

All 2024 2021 2020 2019 2018 2017 2016 2015

All Journal Article Presentation Book

[Book] 薬剤師レジデントマニュアル第3版2021
- Author(s)
  橋田亨, 室井延之, 西岡弘晶（編集）, 池末裕明（分担執筆）
- Total Pages
  422
- Publisher
  医薬書院
- ISBN
  4260045784
- Data Source
  KAKENHI-PROJECT-18K06770
[Book] がん化学療法ワークシート第5版2020
- Author(s)
  池末裕明, 伊藤善規, 大石了三（編集）
- Total Pages
  480
- Publisher
  じほう
- ISBN
  484075277X
- Data Source
  KAKENHI-PROJECT-18K06770
[Book] 病気とくすり20182018
- Author(s)
  池末裕明（分担執筆）
- Total Pages
  1625
- Publisher
  南山堂
- ISBN
- Data Source
  KAKENHI-PROJECT-15K08591
[Book] 病気とくすり20172017
- Author(s)
  池末裕明（分担執筆）
- Total Pages
  1601
- Publisher
  南山堂
- Data Source
  KAKENHI-PROJECT-15K08591
[Book] 病気とくすり2016 基礎と実践2016
- Author(s)
  池末裕明
- Total Pages
  1562
- Publisher
  南山堂
- Data Source
  KAKENHI-PROJECT-15K08591
[Book] がん化学療法レジメン管理マニュアル第2版2016
- Author(s)
  池末裕明（分担執筆）
- Total Pages
  368
- Publisher
  医学書院
- Data Source
  KAKENHI-PROJECT-15K08591
[Book] 臨床の疑問に答えるがん薬物療法アップデート2016
- Author(s)
  池末裕明、増田智先
- Total Pages
  244
- Publisher
  じほう
- Data Source
  KAKENHI-PROJECT-15K08591
[Journal Article] Risk Evaluation of Proton Pump Inhibitors for Panitumumab-Related Hypomagnesemia in Patients with Metastatic Colorectal Cancer2024
- Author(s)
  Katsura Hideyuki、Suga Yukio、Kubo Anna、Sugimura Hayato、Kumatani Kaname、Haruki Kazunobu、Yonezawa Miwa、Narita Ayaka、Ishijima Rei、Ikesue Hiroaki、Toi Hitomi、Takata Naoko
- Journal Title
  
  Biological and Pharmaceutical Bulletin
  
  Volume: 47 Issue: 1 Pages: 98-103
- DOI
  10.1248/bpb.b23-00641
- ISSN
  0918-6158, 1347-5215
- Year and Date
  2024-01-01
- Language
  English
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-23K06251
[Journal Article] Switching from zoledronic acid to denosumab increases the risk for developing medication-related osteonecrosis of the jaw in patients with bone metastases2021
- Author(s)
  Ikesue H, Doi K, Morimoto M, Hirabatake M, Muroi N, Yamamoto S, Takenobu T, Hashida T
- Journal Title
  
  Cancer Chemother Pharmacol
  
  Volume: － Issue: 6 Pages: 871-877
- DOI
  10.1007/s00280-021-04262-w
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-18K06770
[Journal Article] Associated characteristics and treatment outcomes of medication-related osteonecrosis of the jaw in patients receiving denosumab or zoledronic acid for bone metastases2021
- Author(s)
  Ikesue H, Mouri M, Tomita H, Hirabatake M, Ikemura M, Muroi M, Yamamoto S, Takenobu T, Tomii K, Kawakita M, Katoh H, Ishikawa T, Yasui H, Hashida T
- Journal Title
  
  Support Care Cancer
  
  Volume: － Issue: 8 Pages: 4763-4772
- DOI
  10.1007/s00520-021-06018-x
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-18K06770
[Journal Article] Safety evaluation of enzalutamide dose-escalation strategy in patients with castration-resistant prostate cancer2021
- Author(s)
  Miura R, Hirabatake M, Irie K, Ikesue H, Muroi N, Kawakita M, Hashida T
- Journal Title
  
  Urol Oncol
  
  Volume: 233 Issue: 4 Pages: 233.e15-233.e20
- DOI
  10.1016/j.urolonc.2020.09.013
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-18K06770
[Journal Article] Risk Factors for Major Bleeding and Clinically Relevant Non-major Bleeding in Japanese Patients Treated with Edoxaban2020
- Author(s)
  Takase Tomoki、Ikesue Hiroaki、Nakagawa Haruna、Kinoshita Megumi、Muroi Nobuyuki、Kitai Takeshi、Furukawa Yutaka、Hashida Tohru
- Journal Title
  
  Biological and Pharmaceutical Bulletin
  
  Volume: 43 Issue: 3 Pages: 458-462
- DOI
  10.1248/bpb.b19-00799
- NAID
  130007804462
- ISSN
  0918-6158, 1347-5215
- Year and Date
  2020-03-01
- Language
  English
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-18K06770
[Journal Article] Effectiveness of Pharmacist-Physician Collaborative Management for Patients With Idiopathic Pulmonary Fibrosis Receiving Pirfenidone2020
- Author(s)
  Satsuma Y, Ikesue H, Kusuda K, Maeda M, Muroi N, Mori R, Kogo M, Hirabayashi R, Nagata K, Nakagawa A, Tachikawa R, Tomii K, Hashida T
- Journal Title
  
  Front Pharmacol
  
  Volume: － Pages: 529654-529654
- DOI
  10.3389/fphar.2020.529654
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-18K06770
[Journal Article] Evaluation of the usefulness of protocol-based pharmacist-facilitated laboratory monitoring to ensure the safety of immune checkpoint inhibitors in patients with lung cancer2020
- Author(s)
  Ikesue H, Kusuda K, Satsuma Y, Nishiwaki F, Miura R, Masuda Y, Hirabatake M, Muroi N, Fujimoto D, Morimoto T , Tomii K, Hashida T
- Journal Title
  
  J Clin Pharm Ther
  
  Volume: 45 Issue: 6 Pages: 1288-1294
- DOI
  10.1111/jcpt.13207
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-18K06770
[Journal Article] Risk factors for febrile neutropenia induced by docetaxel chemotherapy in patients with non-small cell lung cancer2020
- Author(s)
  Uchida M, Yamaguchi Y, Hosomi S, Ikesue H, Mori Y, Maegawa N, Takano A, Sato Y, Hosohata K, Muroi N, Tomii K, Hashida T, Nakamura T
- Journal Title
  
  Biological and Pharmaceutical Bulletin
  
  Volume: 45 Pages: 00-00
- NAID
  130007883886
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-18K06770
[Journal Article] Risk Factors for Skin Toxicities Associated with Bendamustine-Based Chemotherapy in Patients with Non-Hodgkin Lymphoma2020
- Author(s)
  Uchida Mayako、Mori Yasuhiro、Akiba Kenta、Miyasaka Moena、Hirano Tatsuya、Ikesue Hiroaki、Yamaguchi Yuki、Takano Aoi、Maegawa Nami、Shimomura Yoshimitsu、Hosohata Keiko、Muroi Nobuyuki、Ishikawa Takayuki、Hashida Tohru、Nakamura Tsutomu
- Journal Title
  
  Biological and Pharmaceutical Bulletin
  
  Volume: 43 Issue: 10 Pages: 1577-1582
- DOI
  10.1248/bpb.b20-00428
- NAID
  130007920938
- ISSN
  0918-6158, 1347-5215
- Year and Date
  2020-10-01
- Language
  English
- Peer Reviewed / Open Access / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-20K07143, KAKENHI-PROJECT-19K16429, KAKENHI-PROJECT-18K06768, KAKENHI-PROJECT-18K06770
[Journal Article] Effect of the number of dose adjustment factors on bleeding risk in patients receiving 30?mg/day edoxaban2020
- Author(s)
  Takase Tomoki、Ikesue Hiroaki、Nakagawa Haruna、Kinoshita Megumi、Muroi Nobuyuki、Kitai Takeshi、Furukawa Yutaka、Hashida Tohru
- Journal Title
  
  Journal of Clinical Pharmacy and Therapeutics
  
  Volume: 45 Issue: 2 Pages: 298-302
- DOI
  10.1111/jcpt.13065
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-18K06770
[Journal Article] Comparison of antiemetic effects of granisetron and palonosetron in patients receiving bendamustine-based chemotherapy2018
- Author(s)
  Uchida M, Nakamura T, Makihara Y, Suetsugu K, Ikesue H, Mori Y, Kato K, Shiratsuchi M, Hosohata K, Miyamoto T, Akashi K
- Journal Title
  
  Pharmazie
  
  Volume: 73 Pages: 304-308
- Peer Reviewed / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-15K08591
[Journal Article] Evaluation of pharmaceutical intervention in direct-acting antiviral agents for hepatitis C virus infected patients in an ambulatory setting: a retrospective analysis2018
- Author(s)
  Yamamoto Haruna、Ikesue Hiroaki、Ikemura Mai、Miura Rieko、Fujita Kazumi、Chung Hobyung、Suginoshita Yoshiki、Inokuma Tetsuro、Hashida Tohru
- Journal Title
  
  Journal of Pharmaceutical Health Care and Sciences
  
  Volume: 4 Issue: 1 Pages: 1-8
- DOI
  10.1186/s40780-018-0113-3
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-18K06770
[Journal Article] Interaction between warfarin and short-term intravenous amiodarone in intensive care unit patients after cardiac surgery2018
- Author(s)
  Takase Tomoki、Ikesue Hiroaki、Tohi Makiko、Ueta Hiroshi、Mima Hiroyuki、Koyama Tadaaki、Hashida Tohru
- Journal Title
  
  Journal of Pharmaceutical Health Care and Sciences
  
  Volume: 4 Issue: 1 Pages: 1-8
- DOI
  10.1186/s40780-018-0110-6
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-18K06770
[Journal Article] A case of acute kidney injury associated with dabrafenib and trametinib treatment for metastatic melanoma.2018
- Author(s)
  Ikesue H, Nagano T, Hashida T
- Journal Title
  
  Ann Pharmacother
  
  Volume: 52 Issue: 10 Pages: 1051-2
- DOI
  10.1177/1060028018782985
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-18K06770
[Journal Article] IT支援システムの構築による退院時薬剤情報管理指導の効率化2016
- Author(s)
  鹿子木成美、末次王卓、高田敦史、池末裕明、渡邊裕之、福田未音、了戒百合子、金谷朗子、江頭伸昭、増田智先
- Journal Title
  
  日本病院薬剤師会雑誌
  
  Volume: 52
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-15K08591
[Journal Article] がん骨転移治療薬デノスマブによる低カルシウム血症の発現時期と危険因子2016
- Author(s)
  池末裕明, 秦晃二郎, 了戒百合子, 大畠俊一, 末次王卓, 渡邊裕之, 増田智先
- Journal Title
  
  臨床薬理の進歩
  
  Volume: 37 Pages: 142-148
- Acknowledgement Compliant
- Data Source
  KAKENHI-PROJECT-15K08591
[Journal Article] がん骨転移治療薬デノスマブによる低カルシウム血症の発現時期と危険因子2016
- Author(s)
  池末裕明、秦晃二郎、了戒百合子、大畠俊一、末次王卓、渡邊裕之、増田智先
- Journal Title
  
  臨床薬理の進歩
  
  Volume: 37
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-15K08591
[Journal Article] 集中治療室における注射剤配合変化早見表の作成と有用性の評価2016
- Author(s)
  石田茂、武田真樹、尾川理恵、中島貴史、池末裕明、渡邊裕之、金谷朗子、江頭伸昭、増田智先
- Journal Title
  
  医療薬学
  
  Volume: 42 Pages: 286-294
- NAID
  130005589311
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-15K08591
[Presentation] 臨床現場で取り組むエビデンス創出と人材育成2021
- Author(s)
  池末裕明
- Organizer
  日本臨床腫瘍薬学会学術大会2021
- Invited
- Data Source
  KAKENHI-PROJECT-18K06770
[Presentation] がん薬物療法における薬剤師の役割：深化と広がり2020
- Author(s)
  池末裕明
- Organizer
  第41回日本病院薬剤師会近畿学術大会
- Invited
- Data Source
  KAKENHI-PROJECT-18K06770
[Presentation] 去勢抵抗性前立腺癌におけるエンザルタミド用量漸増法の有害事象評価2020
- Author(s)
  三浦理恵子，平畠正樹，入江慶，池末裕明，室井延之，川喜田睦司，橋田亨
- Organizer
  日本臨床腫瘍薬学会学術大会2020
- Data Source
  KAKENHI-PROJECT-18K06770
[Presentation] Population pharmacokinetics of nivolumab in Japanese patients with non-small cell lung cancer2020
- Author(s)
  Makiko Tohi M, Mizuno T, Irie K, Okuyoshi H, Hirabatake M, Ikesue H, Muroi N, Eto M, Fukushima S, Tomii T, Hashida T
- Organizer
  ASCPT 2020 annual meeting
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-18K06770
[Presentation] 新たな展開を迎えたがん薬物療法を支える薬剤師の育成と広がり2020
- Author(s)
  池末裕明
- Organizer
  日本臨床腫瘍薬学会学術大会2020
- Invited
- Data Source
  KAKENHI-PROJECT-18K06770
[Presentation] がん専門薬剤師の視点から：エビデンス発信と臨床研究教育2020
- Author(s)
  池末裕明
- Organizer
  日本薬学会第140年会
- Invited
- Data Source
  KAKENHI-PROJECT-18K06770
[Presentation] 共に学び伴走する一般病院での研究支援～頼れる先輩薬剤師を目指して～2020
- Author(s)
  池末裕明
- Organizer
  第30回日本医療薬学会年会
- Invited
- Data Source
  KAKENHI-PROJECT-18K06770
[Presentation] ゾレドロン酸からデノスマブへの変更が顎骨壊死発症リスクに与える影響2020
- Author(s)
  土居晃平，池末裕明，平畠正樹，室井延之，竹信俊彦，橋田亨
- Organizer
  第12回日本がん薬剤学会学術大会
- Data Source
  KAKENHI-PROJECT-18K06770
[Presentation] Population pharmacokinetics and clinical outcome of nivolumab in Japanese patients with non-small cell lung cancer2020
- Author(s)
  Tohi M, Mizuno T, Irie K, Okuyoshi H, Hirabatake M, Ikesue H, Muroi N, Eto M, Fukushima S, Tomii K, Hashida T
- Organizer
  18th International Congress of Therapeutic Drug Monitoring & Clinical Toxicology 2020
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-18K06770
[Presentation] 免疫関連有害事象（irAE）とその対策2019
- Author(s)
  池末裕明
- Organizer
  第29回日本医療薬学会年会
- Invited
- Data Source
  KAKENHI-PROJECT-18K06770
[Presentation] チームで取り組むirAEマネジメント2019
- Author(s)
  池末裕明
- Organizer
  医療薬学フォーラム2019/第27回クリニカルファーマシーシンポジウム
- Invited
- Data Source
  KAKENHI-PROJECT-18K06770
[Presentation] 臨床現場からのエビデンス発信に向けた教育の取り組み2019
- Author(s)
  池末裕明
- Organizer
  第4回日本薬学教育学会大会
- Invited
- Data Source
  KAKENHI-PROJECT-18K06770
[Presentation] （シンポジウム）薬剤師が支えるがん薬物療法2018
- Author(s)
  池末裕明
- Organizer
  第11回日本在宅薬学会学術大会
- Invited
- Data Source
  KAKENHI-PROJECT-18K06770
[Presentation] （シンポジウム）入院前から周術期、退院後をつなぐ薬物療法マネジメント2018
- Author(s)
  池末裕明
- Organizer
  医療薬学フォーラム2018／第26回CPシンポジウム
- Invited
- Data Source
  KAKENHI-PROJECT-18K06770
[Presentation] 骨転移を有するがん患者におけるゾレドロン酸関連腎障害のリスク因子解析2018
- Author(s)
  冨田秀明, 池末裕明, 下里萌, 池村舞, 安藤基純, 平畠正樹, 森本茂文, 橋田亨
- Organizer
  第39回日本病院薬剤師会近畿学術大会・第20回近畿薬剤師学術大会
- Data Source
  KAKENHI-PROJECT-15K08591
[Presentation] がん専門薬剤師の役割と貢献2018
- Author(s)
  池末裕明
- Organizer
  第7回がん薬物療法研究討論会
- Invited
- Data Source
  KAKENHI-PROJECT-15K08591
[Presentation] Risk factors for denosumab or zoledronic acid-related osteonecrosis of the jaw in cancer patients with bone metastases2017
- Author(s)
  Ikesue H, Shimosato M, Tomita H, Takenobu T, Hashida T
- Organizer
  52nd ASHP Midyear Clinical Meeting and Exhibition
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-15K08591
[Presentation] 服薬アドヒアランスと副作用マネジメント2016
- Author(s)
  池末裕明
- Organizer
  第22回日本癌治療学会
- Place of Presentation
  パシフィコ横浜（神奈川県・横浜市）
- Year and Date
  2016-10-20
- Invited
- Data Source
  KAKENHI-PROJECT-15K08591
[Presentation] Role of pharmacists in the safe and efficient care of patients receiving cancer treatment2016
- Author(s)
  Ikesue H, Watanabe H, Masuda S.
- Organizer
  FIP World Congress of Pharmacy & Pharmaceutical Sciences 2016
- Place of Presentation
  アルゼンチン国、ブエノスアイレス
- Year and Date
  2016-08-28
- Invited / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-15K08591
[Presentation] ゾレドロン酸誘発腎障害のリスク評価におけるeGFRの有用性2016
- Author(s)
  秦晃二郎、池末裕明、渡邊裕之、江頭伸昭、中西洋一、江藤正俊、赤司浩一、前原喜彦、中村雅史、増田智先
- Organizer
  第14回日本臨床腫瘍学会学術集会
- Place of Presentation
  神戸国際会議場（兵庫県・神戸市）
- Year and Date
  2016-07-28
- Data Source
  KAKENHI-PROJECT-15K08591
[Presentation] デノスマブによる低カルシウム血症のリスク軽減に向けた取組みの有用性2016
- Author(s)
  池末裕明、了戒百合子、秦晃二郎、渡邊裕之、江藤正俊、中西洋一、前原喜彦、赤司浩一、中村雅史、増田智先
- Organizer
  第14回日本臨床腫瘍学会学術集会
- Place of Presentation
  神戸国際会議場（兵庫県・神戸市）
- Year and Date
  2016-07-28
- Data Source
  KAKENHI-PROJECT-15K08591
[Presentation] Association between zoledronic acid-related kidney injury and concomitant administration of hydrophilic rather than lipophilic statins in cancer patients.2015
- Author(s)
  Hata K, Ikesue H, Ohata S, Watanabe H, Masuda S
- Organizer
  50th ASHP Midyear Clinical Meeting & Exhibition
- Place of Presentation
  New Orleans（米国）
- Year and Date
  2015-12-06
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-15K08591
[Presentation] がん患者におけるHMG-CoA還元酵素阻害薬の物理化学的特性に着目したゾレドロン酸誘発腎障害のリスク因子解析2015
- Author(s)
  大畠俊一、池末裕明、秦晃二郎、渡邊裕之、江頭伸昭、増田智先
- Organizer
  第25回日本医療薬学会年会
- Place of Presentation
  パシフィコ横浜（神奈川県・横浜市）
- Year and Date
  2015-11-21
- Data Source
  KAKENHI-PROJECT-15K08591
[Presentation] デノスマブの適正使用に向けた薬剤師の取り組みとアウトカム評価2015
- Author(s)
  了戒百合子、池末裕明、福田未音、秦晃二郎、吉田実、渡邊裕之、江頭伸昭、増田智先
- Organizer
  第23回クリニカルファーマシーシンポジウム/医療薬学フォーラム2015
- Place of Presentation
  名古屋国際会議場（愛知県・名古屋市）
- Year and Date
  2015-07-03
- Data Source
  KAKENHI-PROJECT-15K08591
[Presentation] がん医療の進歩に伴う薬剤師の役割拡大と育薬への貢献を目指して2015
- Author(s)
  池末裕明
- Organizer
  第23回クリニカルファーマシーシンポジウム/医療薬学フォーラム2015
- Place of Presentation
  名古屋国際会議場（愛知県・名古屋市）
- Year and Date
  2015-07-03
- Invited
- Data Source
  KAKENHI-PROJECT-15K08591
[Presentation] ペメトレキセド＋カルボプラチン併用療法による重篤な好中球減少のリスク因子解析2015
- Author(s)
  池末裕明、渡邊裕之、平野めぐみ、近森綾子、末次王卓、了戒百合子、江頭伸昭、高山浩一、中西洋一、増田智先
- Organizer
  第13回日本臨床腫瘍学会学術集会
- Place of Presentation
  ロイトン札幌（北海道・札幌市）
- Year and Date
  2015-07-15
- Data Source
  KAKENHI-PROJECT-15K08591

1. MASUDA Satohiro (90303825)

# of Collaborated Projects: 1 results

# of Collaborated Products: 12 results

Ikesue Hiroaki 池末 裕明

池末 裕明 イケスエ ヒロアキ

IKESUE HIROAKI 池末 裕明

Research Projects

Research Products

Co-Researchers

免疫チェックポイント阻害薬の副作用早期発見のための指標と安全な診療体制の確立Principal Investigator

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Management of adverse events associated with pharmacotherapy in cancer patients with bone metastasisPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Development of monitoring adverse events assciated with bone modifiers in patients cancer bone metastasesPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

[Book] 薬剤師レジデントマニュアル第3版2021

Author(s)

Total Pages

Publisher

ISBN

Data Source

[Book] がん化学療法ワークシート第5版2020

Author(s)

Total Pages

Publisher

ISBN

Data Source

[Book] 病気とくすり20182018

Author(s)

Total Pages

Publisher

ISBN

Data Source

[Book] 病気とくすり20172017

Author(s)

Total Pages

Publisher

Data Source

[Book] 病気とくすり2016 基礎と実践2016

Author(s)

Total Pages

Publisher

Data Source

[Book] がん化学療法 レジメン管理マニュアル第2版2016

Author(s)

Total Pages

Publisher

Data Source

[Book] 臨床の疑問に答える がん薬物療法アップデート2016

Author(s)

Total Pages

Publisher

Data Source

[Journal Article] Risk Evaluation of Proton Pump Inhibitors for Panitumumab-Related Hypomagnesemia in Patients with Metastatic Colorectal Cancer2024

Author(s)

Journal Title

DOI

ISSN

Year and Date

Language

Data Source

[Journal Article] Switching from zoledronic acid to denosumab increases the risk for developing medication-related osteonecrosis of the jaw in patients with bone metastases2021

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Associated characteristics and treatment outcomes of medication-related osteonecrosis of the jaw in patients receiving denosumab or zoledronic acid for bone metastases2021

Author(s)

Journal Title

DOI

Data Source

Ikesue Hiroaki 池末裕明

池末裕明イケスエヒロアキ

IKESUE HIROAKI 池末裕明

[Book] がん化学療法レジメン管理マニュアル第2版2016

[Book] 臨床の疑問に答えるがん薬物療法アップデート2016